PDF  0.07 MB  -  7 pages

The safety analysis of the first 1000 patients treated with MSAD for gastroesophageal reflux disease confirms the safety of this device and the implantation technique.The overall event rates were low based on data from 82 institutions. This content is intended for Health Care Professionals in the United States.